Calamos Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Sell
42,721
-794
-2% -$209K 0.04% 372
2026
Q1
$11.6M Hold
43,515
0.04% 374
2025
Q4
$10.9M Sell
43,515
-1,767
-4% -$469K 0.04% 369
2025
Q3
$13M Hold
45,282
0.05% 359
2025
Q2
$11.9M Hold
45,282
0.05% 368
2025
Q1
$10.5M Buy
45,282
+504
+1% +$122K 0.05% 380
2024
Q4
$10.3M Hold
44,778
0.04% 384
2024
Q3
$10M Sell
44,778
-1,099
-2% -$242K 0.04% 408
2024
Q2
$9.34M Sell
45,877
-1,675
-4% -$341K 0.04% 412
2024
Q1
$10.4M Sell
47,552
-1,196
-2% -$263K 0.05% 386
2023
Q4
$11.1M Sell
48,748
-637
-1% -$134K 0.05% 364
2023
Q3
$9.93M Sell
49,385
-8,099
-14% -$1.71M 0.05% 395
2023
Q2
$11.9M Hold
57,484
0.06% 374
2023
Q1
$11.3M Sell
57,484
-7,187
-11% -$1.48M 0.06% 401
2022
Q4
$13.1M Sell
64,671
-11,435
-15% -$2.23M 0.06% 370
2022
Q3
$13.4M Hold
76,106
0.06% 370
2022
Q2
$15.3M Buy
76,106
+2,049
+3% +$437K 0.07% 326
2022
Q1
$16.8M Buy
74,057
+9,854
+15% +$2.32M 0.06% 342
2021
Q4
$17.3M Sell
64,203
-22,892
-26% -$5.67M 0.06% 306
2021
Q3
$21.1M Buy
87,095
+7,683
+10% +$1.94M 0.09% 239
2021
Q2
$18.8M Buy
79,412
+17,019
+27% +$3.88M 0.09% 262
2021
Q1
$13.7M Sell
62,393
-64,149
-51% -$12.9M 0.07% 279
2020
Q4
$22.1M Sell
126,542
-2,745
-2% -$474K 0.13% 201
2020
Q3
$20.9M Sell
129,287
-6,014
-4% -$953K 0.13% 178
2020
Q2
$19.3M Sell
135,301
-227,378
-63% -$31.5M 0.14% 189
2020
Q1
$39.4M Sell
362,679
-244,370
-40% -$35.2M 0.31% 91
2019
Q4
$88.2M Sell
607,049
-13,879
-2% -$2M 0.44% 50
2019
Q3
$89.6M Sell
620,928
-6,232
-1% -$909K 0.49% 47
2019
Q2
$93.2M Sell
627,160
-70,863
-10% -$9.89M 0.52% 37
2019
Q1
$91.7M Buy
698,023
+67,979
+11% +$8.37M 0.57% 35
2018
Q4
$68.4M Buy
630,044
+25,982
+4% +$3.48M 0.45% 53
2018
Q3
$90.1M Buy
604,062
+137,020
+29% +$20.8M 0.5% 40
2018
Q2
$72M Buy
467,042
+72,453
+18% +$10.9M 0.44% 43
2018
Q1
$54.8M Buy
394,589
+36,978
+10% +$5.43M 0.36% 75
2017
Q4
$49M Buy
357,611
+157,559
+79% +$20.8M 0.25% 80
2017
Q3
$25.9M Buy
200,052
+34,940
+21% +$4.66M 0.2% 156
2017
Q2
$21.9M Buy
165,112
+130,711
+380% +$16M 0.16% 182
2017
Q1
$4.24M Buy
34,401
+1,321
+4% +$156K 0.03% 382
2016
Q4
$3.65M Sell
33,080
-25,034
-43% -$2.78M 0.03% 387
2016
Q3
$6.86M Buy
58,114
+58
+0.1% +$6.83K 0.05% 318
2016
Q2
$6.5M Sell
58,056
-10,174
-15% -$1.09M 0.05% 314
2016
Q1
$6.87M Buy
68,230
+1,773
+3% +$170K 0.05% 303
2015
Q4
$7.06M Sell
66,457
-717,562
-92% -$74M 0.04% 301
2015
Q3
$73.1M Buy
784,019
+5,175
+0.7% +$535K 0.5% 45
2015
Q2
$81.1M Buy
778,844
+185,864
+31% +$19.3M 0.5% 49
2015
Q1
$64.2M Buy
592,980
+315,437
+114% +$32.4M 0.4% 70
2014
Q4
$25.7M Buy
277,543
+267,067
+2,549% +$23.6M 0.17% 158
2014
Q3
$916K Hold
10,476
0.01% 521
2014
Q2
$922K Sell
10,476
-10,476
-50% -$907K 0.01% 529
2014
Q1
$1.77M Hold
20,952
0.01% 453
2013
Q4
$1.65M Hold
20,952
0.01% 454
2013
Q3
$1.78M Buy
20,952
+11,640
+125% +$980K 0.01% 426
2013
Q2
$801K Buy
+9,312
New +$773K 0.01% 476

Other funds holding LH

Calamos Advisors's LH Position: Q2 2026 in Review

Calamos Advisors reduced its Labcorp (LH) stake by 1.8% in Q2 2026, selling an estimated $209K and leaving 42,721 shares worth $12M. The position accounts for 0.04% of the portfolio, ranked #372.

Calamos Advisors first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $93.2M in Q2 2019. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Calamos Advisors held 42,721 shares of Labcorp worth $12M as of Q2 2026.
  • Calamos Advisors sold 794 Labcorp shares in Q2 2026, an estimated $209K.
  • Labcorp made up 0.04% of Calamos Advisors's portfolio in Q2 2026, its #372 holding.
  • Calamos Advisors first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • Calamos Advisors's Labcorp position peaked at $93.2M in Q2 2019.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.